Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
Clinical trial NCT04743141 · RECRUITING
Trial details
- NCT number
- NCT04743141
- Sponsor
- Pfizer
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-28
- Primary completion
- 2030-07-31
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.